While all medications carry potential side effects, certain types have been shown to increase the risk of falls, confusion ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

About 25% of Medicare beneficiaries with dementia were prescribed high-risk central nervous system (CNS) – active medications associated with falls, confusion and hospitalizations between 2013 and ...

Please provide your email address to receive an email when new articles are posted on . An Ohio-based medical device company has secured $85 million in financing to advance a pain management system ...

- Portfolio available in 60+ markets and deepens our CNS footprint in Brazil, South Africa, France and Italy BASILDON, England--(BUSINESS WIRE)--PRESS RELEASE – FOR TRADE, BUSINESS AND MEDICAL MEDIA ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...